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Lentiviral transmission by transfer of infected colostrum and/or milk is considered to be highly efficient. In this study, postpartum transmission
of ovine progressive pneumonia virus (OPPV) from 10 naturally infected ewes to their 23 lambs was followed from the perinatal period
throughout a four-year period. The lambs were allowed to suckle from their dam from birth through 32 weeks of age. Virus was tracked by virus
isolation, quantitative PCR (qPCR), and anti-OPPV antibody responses as measured by cELISA. Cell-associated OPPV was isolated from
colostrum/milk cells in 7 out of 10 ewes and provirus envelope (env) loads ranged 8 to 105 copies/μg DNA in colostrum/milk cells from the 10
ewes using qPCR. Provirus env loads were also detected in the peripheral circulation of 21 lambs at 8 weeks and two lambs at 22 weeks. The
qPCR product at 8 weeks was confirmed as the transmembrane (tm) gene of OPPV by cloning and sequencing. Both cELISA titers ranging from
325 to 3125 and cross-neutralizing antibody titers ranging from 6 to 162 to seven different OPPV strains were found in the colostrum of the 10
ewes. Furthermore, cELISA titers in serum from lambs remained detectable through 32 weeks following the clearance of provirus at 24 weeks.
After 32 weeks, both provirus and anti-OPPV antibody responses have subsequently remained undetectable through 4 years of age. These data
suggest the clearance of cell-associated lentiviruses from lamb circulation after passive transfer of antibody via colostrum.
© 2007 Elsevier Inc. All rights reserved.Keywords: Lentivirus; OPPV; Maedi; Transmission; Colostrum; MilkIntroduction
Mother-to-child transmission (MTCT) of human immuno-
deficiency virus-1 (HIV-1) is believed to occur in utero,
intrapartum, and postpartum. The placenta and the birth canal
are two sources of in utero and intrapartum transmission,
respectively. Breast milk is one postpartum source of HIV-1
accounting for 40% of MTCT (Kourtis et al., 2003). The
contribution of cell-free HIV-1, cell-associated HIV-1, anti-HIV
antibody, and other components in the breast milk to overall
MTCT is not completely understood due to the difficulties in
measuring these parameters on a routine basis in humans. In ad-
dition, the use of highly active antiretroviral therapy (HAART)⁎ Corresponding author. Animal Disease Research Unit, ARS/USDA, 3003
ADBF, Washington State University, Pullman, WA 99164-6630, USA. Fax: +1
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doi:10.1016/j.virol.2006.12.021complicates natural transmission studies by decreasing or
eliminating the available HIV-1 dose.
Ovine progressive pneumonia virus (OPPV) is the sheep
lentivirus counterpart to HIV-1 and infects monocytes, macro-
phages, and dendritic cells (Gendelman et al., 1986; Gorrell et
al., 1992; Ryan et al., 2000). In terms of transmission of OPPV,
which is the North American equivalent to maedi–visna virus
(MVV), in utero transmission occurs, but this route appears to
be inefficient (Brodie et al., 1994; Cross et al., 1974; Cutlip et
al., 1981) and, unlike HIV-1, there have been no studies
conducted on intrapartum transmission of OPPV. Therefore, it
has been postulated that maternal OPPV/MVV transmission
occurs predominantly postpartum through colostrum/milk. The
best evidence for colostrum/milk being involved in transmis-
sion is when lambs are removed immediately from their ewe
after birth, separated from the rest of the seropositive flock, and
artificially reared, they remain seronegative and virus-free their
entire lifetime (De Boer et al., 1979; Houwers et al., 1983). In
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10 h, 6 weeks, or 1 year, the percentage of the lambs infected
based upon serology is 0%, 28%, 76%, and 81%, respectively
(Cutlip and Laird, 1976). Since postpartum transmission occurs
in both OPPV and HIV-1, ewe-to-lamb OPPV transmission
may serve as a good model for lactogenic MTCT HIV-1
transmission.
HIV was isolated from cell-free breast milk of apparently
healthy HIV-infected women (Thiry et al., 1985), and since
then, numerous reports have indicated the presence of cell-free
and cell-associated HIV-1 using predominantly PCR based
virus quantitation methods (Becquart et al., 2006; Koulinska et
al., 2005; Lewis et al., 1998; Rousseau et al., 2004). MVV has
been previously isolated from milk cells of infected sheep
(Lerondelle and Ouzrout, 1990). The isolation of OPPV from
milk cells along with the above epidemiology studies suggests
that colostrum/milk is a transmission source of OPPV. In this
study, our hypothesis was that natural transmission of OPPV
would occur during the lactation period and could be confirmed
by measuring (1) cell-associated OPPV, cell-free OPPV, and
anti-OPPV antibody responses in colostrum/milk of ewes, and
(2) cell-associated OPPV and anti-OPPV antibody responses in
peripheral circulation of lambs. The results of this study showed
that natural postpartum transmission of OPPV was efficient, but
persistent infection was not established.
Results
Virus isolation and qPCR provirus detection in colostrum and
milk
In order to follow natural transmission of OPPV from ewe to
lamb, ten 6-year-old gravid ewes from an Idaho flock with a
history of 84% OPPV seroprevalence were selected. All 10
ewes were confirmed to be OPPV-infected based on the
presence of serum anti-OPPV antibody titers (111–2125)
using the cELISA and mean provirus envelope (env) loads of
6-5448 copies/μg DNA in peripheral blood mononuclear cells
(PBMC) using an OPPV quantitative PCR (qPCR) targeting theTable 1
OPPV infection status of ten lactating ewes
EWE ID Mean serum
cELISA titers a
Mean provirus env load
(copies/μg genomic DNA)
in PBMCa
Mean proviru
(copies/μg ge
in colostrum c
LMH11 133 3471±432 c 26197±2097
LMH12 111 38±9 ud d
LMH13 869 764±42 250±2
LMH14 750 6±1 ud
LMH15 2125 1100±155 47793±230
LMH16 345 197±16 ud
LMH17 205 5448±241 100455±3038
LMH18 835 376±28 ud
LMH19 1825 295±207 2318±53
LMH20 737 45±17 8±3
a Tested within 48 h after parturition.
b Milk cells collected at 2, 4, 6, or 8 weeks post-parturition.
c ±1 SE.
d Undetectable.conserved membrane spanning region of the transmembrane
protein (Table 1). To track OPPV in colostrum/milk of the 10
OPPV-infected ewes, colostrum/milk samples were analyzed
for (1) the presence of cell-associated and cell-free virus by
culturing with goat synovial membrane (GSM) cells and (2) the
amount of cell-associated provirus env loads using OPPV
qPCR. Five ewes (LMH11, LMH13, LMH15, LMH17, and
LMH19) had cell-associated OPPV in their colostrum and three
ewes (LMH11, LMH15, and LMH17) had cell-free OPPV in
their colostrum using in vitro culture with GSM cells (Table 1).
After the second passage, TCID50/ml ranged 2.5×10
5 to
3.2×106 for cell-free colostrum of LMH11, LMH15, and
LMH17. Although cell-associated OPPV was isolated from
milk cells of LMH16 and LMH18, it was not isolated from
colostrum or milk cells from LMH12, LMH14, and LMH20.
Therefore, in 7 out of 10 sheep, OPPV was isolated from
colostrum or milk cells (Table 1).
Mean OPP provirus envelope loads in colostrum cells ranged
from 8 to ∼105 copies/μg DNA and decreased over later milk
cell samplings with the last milk cell sampling at 8 weeks
yielding at least 1–2 logs fewer copies/μg DNA than the
colostrum cell sampling (Fig. 1A). Although cell-associated
virus was not isolated from colostrum or milk cell samplings of
LMH12, LMH14, and LMH20, provirus envelope (env) loads
were detectable at post-parturition in PBMC (mean range=6–
45 copies/μg DNA) and in colostrum cells of LMH20 (mean=8
copies/μg DNA) (Table 1).
Clearance of provirus in lambs
To evaluate whether maternal provirus transmitted to the
lambs, genomic DNA from peripheral blood mononuclear cells
(PBMC) of 21 lambs was analyzed for the presence of provirus
env loads using OPPV qPCR. At 8 weeks, the earliest time that
PBMC were obtained, mean provirus env loads were detected
and ranged 1–69 copies/μg genomic DNA in the 21 examined
lambs (Fig. 1B). Samples were not taken for two lambs
(LMH21 and LMH34) at 8 weeks of age. To confirm the
specificity of the qPCR test, the transmembrane region of thes env load
nomic DNA)
ells
Virus isolation
from colostrum
cells
Virus isolation
from milk cells b
Virus isolation
from cell-free
colostrum
Yes Yes Yes
No No No
Yes Yes No
No No No
Yes Yes Yes
No Yes No
Yes Yes Yes
No Yes No
Yes Yes No
No No No
Fig. 1. (A) Mean provirus envelope loads (copies/μg DNA) in colostrum (week 0) and milk cells (weeks 2, 4, 6, and 8) for the 10 ewes. (B) Mean provirus envelope
loads (copies/μg DNA) in PBMC of the 22 lambs are shown for 8, 22, 24, 26, 28, 32, and 33 weeks post-parturition. The symbols for the lambs match their respective
ewe symbols in panel A (i.e. LMH21 was born to LMH20 and is indicated by an open circle).
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PBMC from LMH32, LMH38, and LMH42, cloned, and
sequenced. At 22 weeks, only two lambs (LMH25 and LMH42)
had detectable provirus env loads, and by 24 weeks and
subsequent weeks, including 210 weeks post-parturition,
provirus env loads were undetectable in all lambs (Fig. 1B
and data not shown).
Evidence of passive transfer of anti-OPPV antibody to lamb
Lambs acquire passive immunity or maternal antibody only
by ingestion of colostrum, and the mucosal absorption of this
antibody occurs only during the first 48 h of life. Thus, cELISA
titers were highest in the colostrum at week 0 or within 24–48 h
after birth (mean=1870) and remained below a mean of 500 in
subsequent milk samples at weeks 2–8 (Fig. 2A). To track
waning maternal antibody and to detect any de novo antibody
responses to OPPV infection, lamb sera were tested every 4
weeks for the presence of anti-OPPV antibodies using cELISA.
Fig. 2B shows that at time zero or pre-suckle sera sampling, all
but two lambs (LMH28 and LMH29) had cELISA titers less
than 30 indicating negative antibody status. The two lambs that
had positive cELISA titers (>30) at time 0 could have suckled
prior to us obtaining the first blood sample. Passive transfer was
demonstrated by showing that ewes had the highest cELISA
titers at week 0 in the colostrum and the lambs had the highest
cELISA titers at week 1 in their sera. In addition, measured
cELISA titers in weeks 1–32 of the lamb sera significantlycorrelated with calculated IgG1 and IgG2 antibody half-life
decay in 22 out of 23 lambs (Pearson correlation 2-tailed
test with 95% confidence, P values=0.0001–0.0476 and
R2 =0.4510–0.8991) (data not shown). This correlation was
performed by assuming the theoretical IgG1 and IgG2 antibody
half-life decay as 11 and 7 days, respectively, and using the first
week lamb cELISA titer as a reference point (Klobasa and
Werhahn, 1989). This supports that the detected anti-OPPV
antibody in the lamb was very likely derived from colostrum
and not from de novo synthesis in the lambs. By week 36, the
mean percent inhibition of the lambs' sera dropped below
20.9% by cELISA indicating that the lambs were negative (Fig.
3). In addition, as another confirmatory serological diagnostic
test, the lamb sera were tested and confirmed negative for OPPV
immunoprecipitating antibodies at weeks 52, 88 and 134 during
the 4-year study (Fig. 3, see arrows).
Evidence of neutralizing antibody
The presence of neutralizing antibody in colostrum may
provide one explanation for the lack of establishment of
persistent infection in the lambs. Therefore, in addition to
measuring anti-OPPV antibody titers in the colostrum by
cELISA, neutralizing antibody titers were also measured. Table
2 shows the nAb reciprocal endpoint titers against 1×102
TCID50 of the various GSM cell-passaged OPP Dubois viruses
isolated from the colostrum cells and OPPV strain WLC1.
Interestingly, colostrum of LMH17 was the only colostrum
Fig. 2. (A) cELISA titers in colostrum (week 0) and milk (weeks 2, 4, 6, and 8) of the ewes. cELISA serum titers represent the inverse of the endpoint serial dilution.
Titers less than 30 are considered negative. (B) cELISA titers in the sera of 23 lambs are plotted against time (0–32 weeks post-parturition). cELISA serum titers
represent the inverse of the endpoint serial dilution. Titers less than 30 are considered negative. The symbols for the lambs match their respective ewe symbols in panel
A (i.e. LMH21 was born to LMH20 and is indicated by an open circle).
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able to neutralize every other virus strain (heterologous) (Table
2). Colostrum from all of the remaining ewes except for LMH15
could neutralize the reference strain (WLC1) and 1 other virus
strain but could not neutralize their own virus strain. The
colostrum of LMH15 failed to neutralize any of the viruses.
This original LMH15 field virus isolated from the colostrum
cells and the LMH15 virus used in the neutralizing antibody
assays both contained a deletion of 5 amino acids in the variable
region 1 (V1) of the envelope gene (Herrmann et al., 2004).Fig. 3. Mean percent inhibition in sera of the 22 lambs (LMH21–LMH37,
LMH39–43) using the cELISA is plotted against time (weeks post-parturition).
Error bars represent ±1 standard deviation. Arrows indicate where immuno-
precipitation of 35[S] methionine/cysteine-labeled OPPV WLC1 was negative
for the 22 lamb sera. The horizontal line indicates a cut-off value of 20.9%
inhibition. Percent inhibitions >20.9 are considered positive test sample as
previously determined in Herrmann et al. (2003).Horizontal transmission of OPPV from ewes to a younger,
unrelated ewe
In order to verify that the Dubois OPPV strains were capable
of infecting sheep, an OPPV-negative 3-year-old Suffolk ewe
(112-45) from a different OPPV-negative source flock was
placed with the OPPV ewes for 2 years. Ewe 112-45 serocon-
verted as measured by cELISA (>20.9% inhibition) and has
maintained seropositive status for 8 months with detection of
provirus env loads. This indicates that OPPV in the original
group of ewes was infectious and capable of causing serocon-
version and persistent infection via horizontal transmission.Table 2
Neutralizing activity of colostrum antibodies against OPPV strains isolated from
colostrum cells and a reference OPPV strain, WLC1
Colostrum
LMH11 LMH13 LMH15 LMH16 LMH17 LMH19
Virus
WLC1 a 18 b 54 * 6 162 6
LMH11 * c * * 18 54 54
LMH13 * * * * 18 *
LMH15 * * * * 18 6
LMH16 54 * * * 162 *
LMH17 18 6 * * 162 18
LMH19 6 * * * 18 *
a Reference strain.
b Reported as endpoint reciprocal titers.
c A titer <6 is considered negative for neutralization against 1×102 TCID50
and is shown as *.
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OPP provirus was detected in the peripheral circulation at
week 8 in the lambs and confirmed by targeted sequencing.
However, by 24 weeks, provirus was undetectable and remained
undetectable throughout 4 years of age. In addition, none of the
lambs established a long-term persistent infection as measured
by cELISA, immunoprecipitation, and qPCR tests. These data
strongly indicate that the lambs acquired provirus but then
cleared it.
There are two potential transmission routes that could
account for the detection of provirus in the peripheral
circulation of the lambs. One mechanism is that cell-free and
cell-associated virus in the colostrum infected the lambs by the
gastrointestinal tract. In a previous report, MVV capsid and
provirus were detected in intestinal epithelial cells, mono-
nuclear cells of the lamina propria, mesenteric lymph nodes, and
ileum Peyer's patches of neonatal lambs using immunohisto-
chemistry and in situ hybridization (Preziuso et al., 2004). In
addition, maternal leukocytes are known to be intestinally
absorbed in newborn lambs and enter peripheral circulation
(Schnorr and Pearson, 1984). Our results along with these
previous reports suggest that lambs are exposed to both cell-free
virus and provirus from colostrum via the gastrointestinal tract.
Another potential OPPV transmission route for acquisition of
cell-free and cell-associated virus (provirus) is the respiratory
tract by aspirating milk during suckling or during normal
respiration. Recent experimental intranasal and intratracheal
inoculations of maedi–visna virus into sheep have shown that
the intratracheal route of experimental infection is a more
efficient route of infection than intranasal (Torsteinsdottir et al.,
2003). However, a detailed temporal study has not been
conducted on naturally or experimentally OPPV-infected sheep.
Therefore, it is unknown whether the respiratory tract contains
virus prior to other tissues.
One possibility for the lack of established persistent infection
in the lambs is that virus loads in the colostrum/milk and other
contact sources were too low in the ewes to establish a persistent
infection in the lambs. Horizontal transmission and the
establishment of persistent infection in an unrelated ewe
indicated that the OPPV was fully infectious. Concomitantly
passively transferred antibodies could block establishment of
persistent infection, especially with a viral dose close to the
minimal infectious dose. Passive transfer was demonstrated by
showing that ewes had the highest cELISA titers at week 0 in
the colostrum and the lambs had the highest cELISA titers at
week 1 in their sera. Temporally, cELISA titers remained
detectable after provirus was cleared in all lambs, consistent
with the possibility that passively transferred antibody plays a
role in provirus clearance. In addition, the decay of cELISA
titers in 22 out of 23 lamb sera correlated with both IgG1 and
IgG2 half-life decay curves which suggests that an antibody
mediated clearance was associated with passive transfer of
antibody and not de novo antibody responses produced by the
lambs.
Studies have correlated lower MTCT and improved clinical
conditions in children with the presence of antibody dependentcellular cytotoxicity (ADCC) and neutralizing antibody in their
serum (Barin et al., 2006; Ljunggren et al., 1990). Neutralizing
antibodies are important for binding to cell-free virus and
blocking cell-free virus from infecting myeloid-based cells.
Previous studies have shown that passive transfer of anti-HIV-1
neutralizing monoclonal antibodies to rhesus macaques con-
ferred protection against infection after SHIV challenge
(Hofmann-Lehmann et al., 2002; Mascola et al., 1999; Xu et
al., 2002). In our study, cross-neutralizing antibody in the
colostrum of 5 out of 6 ewes was observed where the colostrum
of these ewes could neutralize OPPV WLC1 and 1 other OPPV
Dubois strain. Autologous neutralizing antibody was only
observed in the colostrum from LMH17 and was not observed
in the colostrum from LMH11, LMH13, LMH15, LMH16, and
LMH19. The absence of autologous neutralizing antibody to
HIV-1 is associated with MTCT, and the presence of cross-
neutralizing antibody in serum is associated with slow
progression and low risk transmission in primate lentivirus
infections (Fenyö and Putkonen, 1996; Lathey et al., 1999). In
addition, in utero transmitters of HIV-1 are significantly less
likely to have autologous neutralizing antibody (Dickover et al.,
2006). Therefore, if the presence of autologous neutralizing
antibody in colostrum is necessary for protection against
infection, the progeny of LMH11, LMH13, LMH15, LMH16
and LMH19 should have become persistently infected. How-
ever, since the progeny of these ewes did not establish persistent
infection, it suggests that the presence of autologous neutraliz-
ing antibody alone is neither predictive of nor sufficient for
clearance of OPPV following maternal transmission.
If the presence of cross-neutralizing antibody in colostrum is
sufficient to protect lambs from cell-free virus infection, then
the progeny of LMH15 should have become persistently
infected. However, neither of the two remaining lambs of
LMH15 became persistently infected (LMH38 died due to
trauma at 5 months). There are two major differences in the
variable regions of the envelope gene between LMH15 virus
and other viruses isolated from colostrum cells (Herrmann et al.,
2004). LMH15 contains a 5 amino acid deletion in the variable
1 (V1) region of the envelope gene, and it also contains a
tyrosine residue in place of an arginine, asparagine, or lysine at
amino acid position 573 in the V4 region of Genbank accession
#64439 which is part of the only known maedi–visna virus
neutralizing epitope (Skraban et al., 1999). Therefore, the V1
deletion and/or the mutation in the neutralizing epitope of
LMH15 virus could have either inhibited the generation of
cross-neutralizing antibody or attenuated the virus in vivo.
Other potential antibody-induced mechanisms for provirus
clearance include activation of natural killer cells through Fc
receptors by antibody dependent cellular cytotoxicity (ADCC)
and activation of phagocytosis through Fc receptors on cells of
myeloid origin. High serum titers of anti-HIVADCC antibodies
positively correlate with CD4+ T-cell counts and negatively
correlate with plasma viremia (Ahmad et al., 2001). We plan on
further investigating the role of ADCC and Fc receptor
mediated processes on provirus clearance using colostrum.
Others have suggested that lamb-to-lamb MVV horizontal
transmission may contribute more to overall MVV transmission
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suckling (Alvarez et al., 2005, 2006). To establish whether
OPPV was transmitted from ewes to lambs or from lambs to
lambs in our study, we are currently evaluating the OPPV
strains via envelope sequence in PBMC of the lambs at 8 weeks
of age. OPPV/MVV transmission studies may be useful models
for MTCTof HIV-1 and may offer enlightenment to discovering
protective factors in breast milk that may be critical to thwarting
lactogenic HIV-1 transmission.
We have shown efficient transmission of OPPV from
lactating ewes to suckling lambs. However, the immunological
and viral determinants that result in transient provirus acquisi-
tion without establishment of a persistent infection remain
unknown. Full evaluation of ADCC antibody, neutralizing
antibody, and viral strains in the colostrum of older and younger
ewes may lead to new information regarding the efficiency of
lactogenic transmission and effective anti-lentivirus therapies.
Materials and methods
Animals
Ten gravid 6-year-old Columbia, Polypay, and Rambouillet
ewes tested positive for OPPV based upon the presence of
serum antibodies which (1) inhibit the binding of monoclonal
antibody 74A to CAEV surface glycoprotein (SU) in a
competitive inhibition ELISA (cELISA) and (2) immunopreci-
pitate (IP) major viral structural proteins in 35S-methionine
labeled OPPV WLC1 viral lysates (Herrmann et al., 2003,
2005). The 10 ewes gave birth to a total of 23 lambs in one
season. Three of the ewes (LMH11, LMH15 and LMH16) gave
birth to triplets and could not keep up with adequate milk
production. Therefore, one lamb from each of these triplets was
removed from its ewe 48 h after birth and artificially raised with
milk replacer (LMH30, LMH34, and LMH38). Lambs were
allowed to suckle naturally for 32 weeks followed by separation
from the ewes by a fence. The lamb and ewe groups at this point
had nose-to-nose contact through the fence but did not share
automatic watering devices. In March 2003, one unbred 3-year-
old OPPV-negative Suffolk ewe (112-45) from a different
source flock was placed into the 10 OPPV-positive ewe group.
In August 2003, LMH11 was experiencing cachexia and was
euthanized and necropsied in September 2003. In April 2005,
the remaining 9 OPPV-positive ewes (LMH12–LMH20) were
euthanized and necropsied.
Blood collection
Blood was drawn from the ewes by jugular venous puncture
into a 60 cm3 syringe containing 10 mM EDTA and into a 10 ml
serum vaccutainer tube at post-parturition (the day after
lambing). Blood was drawn from the lambs by jugular venous
puncture into a 2 ml serum vaccutainer tube immediately after
the lambs were born prior to colostrum intake. For the first week
through 6 weeks of life, 2 ml of blood from the lambs was
drawn for serology. After this time, approximately 5–10 ml of
blood was drawn from the lambs by jugular puncture into a10 ml EDTA and serum vaccutainer tube for PBMC isolation
and serum isolation, respectively.
cELISA and immunoprecipitations (IP)
Serum was isolated by centrifugation at 1000×g, and the
caprine arthritis-encephalitis virus (CAEV) cELISA and IP
were performed on serum as previously described (Herrmann
et al., 2003, 2005). This CAEV cELISAwas recently validated
against the serological standard of comparison, immunopreci-
pitation (IP) of 35[S]-labeled methionine/cysteine OPPV
WLC1, and exhibits 98.6% sensitivity and 96.9% specificity
in sheep (Herrmann et al., 2003). cELISA titers in cell-free
colostrum/milk or serum were determined by endpoint dilution
methods using previous methods (Herrmann et al., 2005).
Colostrum and milk sample collection
Before or within 24 h after parturition, 15–30 ml of
colostrum was collected from each ewe by hand milking.
Every 2 weeks after parturition, 25–50 ml of milk from the 10
ewes was collected by hand milking. Colostrum/milk samples
were divided in half, diluted 1:1 with 1× PBS Dulbecco's pH
8.0, and centrifuged at 500×g for 10 min at 4 °C. Butterfat layer
was removed and discarded, and the supernatant was poured
into another clean tube and frozen at −80 °C for cell-free
colostrum and milk experiments. The colostrum/milk cells
isolated from the first half of the colostrum/milk samples were
used in co-culture experiments, and the colostrum/milk cells
isolated from the second half were used in OPPV qPCR.
Colostrum cell, milk cell, and peripheral blood mononuclear
cell (PBMC) isolation
Colostrum/milk cells used for OPPV qPCR were washed 2
more times with 1× PBS Dulbecco's pH 8.0 and centrifuged at
500×g for 10 min at 4 °C. PBMC were isolated using previous
gradient purification techniques (Herrmann et al., 2001). Cells
were counted using 0.2% trypan blue on a Neubauer
hemocytometer. Cell pellets were frozen at −20 °C for DNA
isolation followed by OPPV qPCR.
Colostrum and milk cell co-culture
Colostrum/milk cells used for co-culture experiments were
washed 2× with DMEM 10% fetal bovine serum (FBS)
containing 100 μg/ml gentamycin and 100 U/ml penicillin/
streptomycin by resuspension and centrifugation at 500×g for
10 min at 4 °C. The final pellet of colostrum or milk cells was
resuspended into 1 ml media and split between 2 and 25 cm2
flasks containing goat synovial membrane cells (GSM) at
approximately 50% confluence. GSM cells were previously
isolated from the synovium joint of goat kids born out of a well-
established CAEV-free goat-herd (Klevjer-Anderson and Che-
evers, 1981). The co-cultures were maintained in DMEM 5.0%
FBS containing 100 μg/ml gentamycin and 100 U/ml penicillin/
streptomycin. The cells were passed as needed and observed for
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visualized, half the supernatant was passed onto new GSM
cells as a second check for syncytia and the other half was
frozen at −80 °C. Virus was isolated from the supernatants and
the TCID50 was determined in GSM cells using previous
methods (Klevjer-Anderson and Cheevers, 1981).
Cell-free colostrum and milk in culture with GSM cells
Cell-free colostrum or milk was thawed from the −80 °C and
30 ml of cell-free colostrum or milk was placed onto 75 cm2
flasks containing GSM cells at 50% confluence. After 1 day, the
cell-free colostrum and milk were removed and GSM cells were
allowed to incubate, passed as necessary, and monitored for
syncytia formation over 6 weeks. If syncytia were observed, the
supernatant was passed onto fresh GSM cells for a second
passage. If syncytia were observed in the second passage, the
virus was titered using previously established methods (Klevjer-
Anderson and Cheevers, 1981).
DNA isolation
DNA from colostral cells, milk cells, and peripheral blood
mononuclear cells was isolated using a DNA isolation kit for
1×106 or 1×107 cells following the manufacturer's instructions
(Gentra Puregene D-5000K).
PCR amplification, and cloning of envelope (env) from OPPV
field isolates
PCR amplification of env, cloning, and sequencing of
envelope from 7 OPPV field isolates were previously described
(Herrmann et al., 2004). PCR amplification of the transmem-
brane region of env was performed using the same protocols for
the entire env except primers TMENVCONf and TMENV-
CONr (see below) were utilized in the initial PCR amplification.
Real-time OPPV quantitative PCR (qPCR) of env in colostrum
and milk cells
TaqMan probe and primers were designed using Beacon
Designer (Premier Biosoft version 2.1) based upon a consensus
sequence derived from plasmid env clones LMH15-6 pCR2.1,
LMH16-3 pCR2.1, LMH17-5 pCR2.1, and LMH19-5 pCR2.1
from 4/10 OPPV-positive ewes (Herrmann et al., 2004). The
probe and primers target the highly conserved sequence
encoding the transmembrane protein. TaqMan® anti-sense
probe was used 5′-/5HEX/AGC AAC ACC GAG ACC AGC
TCC TGC/3BHQ-1/-3′ (IDT) which is located at bp position
2033 in the env sequence of Genbank accession #U64439.
Primers used in real-time Taqman® PCR were TMENVCONf
5′-TCA TAG TGC TTG CTATCATGG CTA-3′ and TMENV-
CONr 5′-CCG TCC TTG TGT AGG ATT GCT-3′. TaqMan®
Universal PCR 2× Master Mix (Applied Biosystems), 300 nMf
primers, 250 nMf TaqMan® probe, and up to 1 μg DNA isolated
from the colostrum and milk cells were used in a 50 μl total
volume real-time PCR reaction. An I-cycler iQ (BioRad) wasused in real-time PCR and the following amplification
conditions were applied: 95 °C 10 min, 60 cycles of 95 °C
for 15 s and 55 °C for 60 s, and 4 °C indefinite. Triplicate
reactions of control plasmid clone LMH17-5 pCR2.1 ranging
10−1 to 106 copies were used to generate a standard curve. One
copy of plasmid was detected in triplicate in all qPCR tests, and
therefore one copy serves as the lower limit of detection for the
qPCR test. Negative controls contained all components above
except DNA and were run in triplicate. Sample unknowns were
also run in triplicate. A standard curve was constructed by
plotting logarithmic copy number versus threshold cycle (CT)
using PCR baseline subtracted curve fit (BioRad I-cycler
software). Copy number of the unknown samples in the
experiment was determined using the mean CT value and the
equation of the line generated in the standard curve. The mean
copy number and standard error (n=3) of the mean copy
number were calculated.
Neutralization antibody assays on cell-free colostrum and milk
Neutralization antibody (nAb) titers were determined for
cell-free, heat-inactivated colostrum and milk samples using a
similar established method with some modifications using
OPPV WLC1 or Dubois OPPV isolates as the infecting virus
(McGuire et al., 1988). OPPV WLC1 and Dubois OPPV field
isolate infectivity titers (TCID50) were determined on GSM
cells. For nAb assays, briefly, 3-fold serial dilutions of cell-free,
heat-inactivated (60 °C for 1 h) colostrum or milk (previously
diluted 1:2 with 1× PBS Dubellco's pH 8.0) from the Dubois
sheep were made in DMEM with 2% fetal bovine serum. One
hundred microliters of the different serial dilutions of colostrum
or milk was incubated with 100 μl OPPV WLC1 or Dubois
isolate at 1×103 TCID50 ml at 37 °C for 1 h followed by 4 °C
for 18 h. This mixture was then added to 6×103 GSM cells/well
in quadruplicate on a 96-well plate and incubated at 37 °C for
1 h. To ensure that cell-free, heat-inactivated colostrum or milk
did not destroy the GSM monolayer, 100 μl of the different
serial dilutions of cell-free, heat-inactivated colostrum or milk
was placed on 6×103 GSM cells/well in quadruplicate on
another 96-well plate and was incubated at 37 °C for 1 h. As a
positive control, 100 μl of 1×103 TCID50/ml of the different
viruses was directly added to 6×103 GSM cells/well in
quadruplicate. The virus/colostrum mixture, colostrum, or
virus was removed from the GSM cells after 1 h at 37 °C,
100 μl of DMEM with 2% FBS was added, and the cells were
incubated for 8 days at 37 °C. At the end of 8 days, media was
removed; cells were fixed with methanol, rinsed with water, and
stained with Giemsa (diluted 1:30 with water) for 2 h. The
dilution of cell-free colostrum or milk in which syncytia could
not be detected in ≥3 out of 4 wells was scored positive for
neutralization. Neutralizing antibody (nAb) titers were reported
as the reciprocal of the dilution of cell-free colostrum or milk.
The envelope gene from GSM passaged OPPV field isolates
used in the neutralization antibody assays was re-cloned and
sequenced using previous methods (Herrmann et al., 2004). In
all the field viruses used in the neutralizing antibody assays,
there was less than or equal to 2.5% deduced amino acid
233L.M. Herrmann-Hoesing et al. / Virology 362 (2007) 226–234differences in envelope when compared to the deduced amino
acid sequences from the original field viruses isolated from
colostrum cells.
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